Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Enterovirus as trigger of coeliac disease: nested case-control study within prospective birth cohort

CR. Kahrs, K. Chuda, G. Tapia, LC. Stene, K. Mårild, T. Rasmussen, KS. Rønningen, KEA. Lundin, L. Kramna, O. Cinek, K. Størdal,

. 2019 ; 364 (-) : l231. [pub] 20190213

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc19027820

OBJECTIVE: To determine whether infection with human enterovirus or adenovirus, both common intestinal viruses, predicts development of coeliac disease. DESIGN: Case-control study nested within Norwegian birth cohort recruited between 2001 and 2007 and followed to September 2016. SETTING: Norwegian population. PARTICIPANTS: Children carrying the HLA genotype DR4-DQ8/DR3-DQ2 conferring increased risk of coeliac disease. EXPOSURES: Enterovirus and adenovirus detected using real time polymerase chain reaction in monthly stool samples from age 3 to 36 months. MAIN OUTCOME MEASURE: Coeliac disease diagnosed according to standard criteria. Coeliac disease antibodies were tested in blood samples taken at age 3, 6, 9, and 12 months and then annually. Adjusted odds ratios from mixed effects logistic regression model were used to assess the relation between viral infections before development of coeliac disease antibodies and coeliac disease. RESULTS: Among 220 children, and after a mean of 9.9 (SD 1.6) years, 25 children were diagnosed as having coeliac disease after screening and were matched to two controls each. Enterovirus was found in 370 (17%) of 2135 samples and was significantly more frequent in samples collected before development of coeliac disease antibodies in cases than in controls (adjusted odds ratio 1.49, 95% confidence interval 1.07 to 2.06; P=0.02). The association was restricted to infections after introduction of gluten. High quantity samples (>100 000 copies/μL) (adjusted odds ratio 2.11, 1.24 to 3.60; P=0.01) and long lasting infections (>2 months) (2.16, 1.16 to 4.04; P=0.02) gave higher risk estimates. Both the commonly detected enterovirus species Enterovirus A and Enterovirus B were significantly associated with coeliac disease. The association was not found for infections during or after development of coeliac disease antibodies. Adenovirus was not associated with coeliac disease. CONCLUSIONS: In this longitudinal study, a higher frequency of enterovirus, but not adenovirus, during early childhood was associated with later coeliac disease. The finding adds new information on the role of viral infections in the aetiology of coeliac disease.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19027820
003      
CZ-PrNML
005      
20190822084724.0
007      
ta
008      
190813s2019 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1136/bmj.l231 $2 doi
035    __
$a (PubMed)30760441
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Kahrs, Christian R $u Department of Pediatrics, Østfold Hospital Trust, Grålum, Norway. Norwegian Institute of Public Health, Oslo, Norway. Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
245    10
$a Enterovirus as trigger of coeliac disease: nested case-control study within prospective birth cohort / $c CR. Kahrs, K. Chuda, G. Tapia, LC. Stene, K. Mårild, T. Rasmussen, KS. Rønningen, KEA. Lundin, L. Kramna, O. Cinek, K. Størdal,
520    9_
$a OBJECTIVE: To determine whether infection with human enterovirus or adenovirus, both common intestinal viruses, predicts development of coeliac disease. DESIGN: Case-control study nested within Norwegian birth cohort recruited between 2001 and 2007 and followed to September 2016. SETTING: Norwegian population. PARTICIPANTS: Children carrying the HLA genotype DR4-DQ8/DR3-DQ2 conferring increased risk of coeliac disease. EXPOSURES: Enterovirus and adenovirus detected using real time polymerase chain reaction in monthly stool samples from age 3 to 36 months. MAIN OUTCOME MEASURE: Coeliac disease diagnosed according to standard criteria. Coeliac disease antibodies were tested in blood samples taken at age 3, 6, 9, and 12 months and then annually. Adjusted odds ratios from mixed effects logistic regression model were used to assess the relation between viral infections before development of coeliac disease antibodies and coeliac disease. RESULTS: Among 220 children, and after a mean of 9.9 (SD 1.6) years, 25 children were diagnosed as having coeliac disease after screening and were matched to two controls each. Enterovirus was found in 370 (17%) of 2135 samples and was significantly more frequent in samples collected before development of coeliac disease antibodies in cases than in controls (adjusted odds ratio 1.49, 95% confidence interval 1.07 to 2.06; P=0.02). The association was restricted to infections after introduction of gluten. High quantity samples (>100 000 copies/μL) (adjusted odds ratio 2.11, 1.24 to 3.60; P=0.01) and long lasting infections (>2 months) (2.16, 1.16 to 4.04; P=0.02) gave higher risk estimates. Both the commonly detected enterovirus species Enterovirus A and Enterovirus B were significantly associated with coeliac disease. The association was not found for infections during or after development of coeliac disease antibodies. Adenovirus was not associated with coeliac disease. CONCLUSIONS: In this longitudinal study, a higher frequency of enterovirus, but not adenovirus, during early childhood was associated with later coeliac disease. The finding adds new information on the role of viral infections in the aetiology of coeliac disease.
650    _2
$a autoprotilátky $x krev $7 D001323
650    _2
$a studie případů a kontrol $7 D016022
650    _2
$a celiakie $x virologie $7 D002446
650    _2
$a dítě $7 D002648
650    _2
$a předškolní dítě $7 D002675
650    _2
$a Enterovirus $x izolace a purifikace $7 D004770
650    _2
$a enterovirové infekce $x komplikace $x epidemiologie $7 D004769
650    _2
$a feces $x virologie $7 D005243
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a genotyp $7 D005838
650    _2
$a lidé $7 D006801
650    _2
$a kojenec $7 D007223
650    _2
$a longitudinální studie $7 D008137
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a prospektivní studie $7 D011446
650    _2
$a kvantitativní polymerázová řetězová reakce $7 D060888
650    _2
$a rizikové faktory $7 D012307
651    _2
$a Norsko $x epidemiologie $7 D009664
655    _2
$a časopisecké články $7 D016428
700    1_
$a Chuda, Katerina $u Department of Paediatrics, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic.
700    1_
$a Tapia, German $u Norwegian Institute of Public Health, Oslo, Norway.
700    1_
$a Stene, Lars C $u Norwegian Institute of Public Health, Oslo, Norway.
700    1_
$a Mårild, Karl $u Department of Pediatrics, Institute of Clinical Sciences, The Sahlgrenska Academy at University of Gothenburg and Queen Silvia Children's Hospital, Gothenburg, Sweden.
700    1_
$a Rasmussen, Trond $u Department of IT and e-health, Division of Institute Resources, Norwegian Institute of Public Health, Oslo, Norway.
700    1_
$a Rønningen, Kjersti S $u Department of Pediatric Research, Oslo University Hospital, Oslo, Norway.
700    1_
$a Lundin, Knut E A $u Department of Gastroenterology, Oslo University Hospital Rikshospitalet, Oslo, Norway. K.G. Jebsen Coeliac Disease Research Centre, University of Oslo, Oslo, Norway.
700    1_
$a Kramna, Lenka $u Department of Paediatrics, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic.
700    1_
$a Cinek, Ondrej $u Department of Paediatrics, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic.
700    1_
$a Størdal, Ketil $u Department of Pediatrics, Østfold Hospital Trust, Grålum, Norway. Norwegian Institute of Public Health, Oslo, Norway.
773    0_
$w MED00193492 $t BMJ (Clinical research ed.) $x 1756-1833 $g Roč. 364, č. - (2019), s. l231
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30760441 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190813 $b ABA008
991    __
$a 20190822085002 $b ABA008
999    __
$a ok $b bmc $g 1432969 $s 1066280
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 364 $c - $d l231 $e 20190213 $i 1756-1833 $m BMJ $n BMJ $x MED00193492
LZP    __
$a Pubmed-20190813

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...